Bioprocess Containers Market

Global Bioprocess Containers Market Size

The global bioprocess containers market was valued at USD 8.77 billion in 2025, is estimated to reach USD 11.28 billion in 2026, and is projected to hit USD 84.72 billion by 2034, growing at a CAGR of 28.66% from 2026 to 2034

Increasing usage of single-use technologies for COVID-19 pandemic-related research and growing vaccine development by key players are the major factors that positively impact the bioprocess container market.

To meet the current market's expectations, market players are investing significantly in developing innovative single-use products, such as intelligent single-use linked temperature sensors. Several advanced approaches are used in COVID-19 vaccine initiatives, such as mRNA, DNA vaccines, and vectors based on single-use technology. Due to their low cost, high speed, and significantly reduced initial expenditure compared to conventional stainless-steel equipment, most of them used this single-use product during the pandemic.

MARKET DRIVERS

Rising Cancer Cases and Adoption of Single-Use Bioprocess Technologies

The growing number of cancer cases worldwide is majorly promoting the growth of the bioprocess container market. Increased incidence of cancer and immunological disorder, which requires vaccines and biologics, and an increased preference for immunotherapy over chemotherapy. In 2019, according to the American Cancer Society report, about 1,762,456 new cancer cases were diagnosed, and 606,889 cancer deaths were reported in the United States, demanding treatment with advanced and efficient methods.

The growing usage of single-use disposable technologies is another major factor boosting the bioprocess container market. Single-use technology products are widely used to produce vaccines and biologics, with fewer cleaning and sterilization processes, reduced cross-contamination risks, shorter setup times, and cost- and time-saving benefits. Single-use Systems are considered a commercially viable strategy to achieve maximum process efficiency and productivity by several end-users. In addition, adopting analytical models based on big data and machine learning is projected to improve product yields based on the prediction process. Single-use equipment and supplies are used because the active creation of customized biologics and medicines, such as patient-specific cellular and gene therapies and therapeutic vaccines, requires a lot of purity.

Factors such as the Y-O-Y rise in the biologics market, affordability and durability of single-use bioprocess technologies, use of data, digital technologies, and AI, increased expectations of success, increased biopharmaceutical R&D, rise in the approval of new drugs by the FDA, and the launch of new products expected to favor the growth rate of the bioprocess containers market. Adopting next-generation technologies into their products, such as depth filtration, disposable chromatography, sterile filtration, ultrafiltration, and virus filtration, for better sample protection, productivity, and other benefits. Using single-use bioreactors during the production of the vaccine reduces the cross-contamination in the vaccine and is one of the opportunities for market growth.

MARKET RESTRAINTS

High Costs, Regulatory Barriers, and Waste Management Issues

Issues regarding extractable and leachable from single-use bioprocessing system components, high cost of instruments, time consumption as compared to the chemical process method, stringent regulations for the implementation of disposable systems, and problems associated with the usage of plastic-based disposable products, lack of awareness towards innovative applications of disposables in bioproduction are a few of the key factors expected to restrain the bioprocess containers market growth. In addition, the solid waste generated from the single-use container is the major challenge for the bioprocess container market. Single-use components are made up of polyethylene, polypropylene, ethylene vinyl alcohol, or nylon, and such products are not suited for recycling.

REPORT COVERAGE

SEGMENTAL ANALYSIS

By Type Insights

Based on type, the 2D bioprocess containers segment held the highest share of the global bioprocess containers market in 2024. These 2D bioprocess containers are widely used in cell harvesting and transporting bulk drug products and precursors. The 2D bioprocess container is a bioprocess container with a two-dimensional design for handling sterile liquid. They are made for small, simple BPCs from 50 ML to 50 L. These containers play an essential role in the pharmaceutical industry's handling and transporting processes, reducing the time required to handle and transfer biological products. These bag demands are increasing due to affordability, durability, and reduced risk, which are other key factors driving the growth of the bioprocess container market.

By Application Insights

Based on the application, the upstream processes segment is anticipated to be the largest share among all in the global bioprocess containers market during the forecast period owing to the rise in demand for cell therapy research, drug discovery, antibody synthesis, monoclonal antibody, and recombinant products. In addition, upstream processes use bioprocess containers, especially during fermentation and culture media processing.

By End-User Insights

Based on the end-user, the pharmaceutical & biopharmaceutical companies’ segment accounted for the highest share of the global bioprocess containers market in 2021. The aged people are more prone to various disorders that can be treated using biologics is the primary factor in the development of the market. This has resulted in the development of biologics at a lower rate. In addition, adopting automation in the bioprocessing market has exponentially driven biomanufacturing growth.

REGIONAL ANALYSIS

Geographically, the North American region accounted for a significant share of the global bioprocess container market in 2024 due to the high demand for biopharmaceuticals, huge healthcare investments, leading players focusing on research activities and advanced healthcare infrastructure in the United States. In addition, the United States and Canada led the North American bioprocess containers market due to rising demand for vaccine production, the presence of various major companies, an increase in the prevalence of people suffering from various diseases, a rise in initiatives undertaken by governments, and the spread of awareness regarding the advantages of vaccines.

Europe had the second largest share in the global market in 2022 with a rise in life science R&D companies, government spending on R&D, advanced products in the region, and biologics and biosimilar manufacturing. Germany and the United Kingdom led the European market in 2021. The need for single-use bioprocess systems is anticipated to accelerate in Germany as the country's biopharmaceutical and biotech industries grow.

The Asia Pacific market is predicted to have a healthy CAGR during the forecast period, and this is due to the significant investments by key market players, an increase in funding, and support from the governments in the region. Countries such as China, India, and Japan fuel the region’s occupancy in the global market with a high R&D infrastructure of pharmaceutical manufacturing, advanced developments, and comparatively cheaper labor costs. Among these countries, China dominates the region due to domestic demand for cell culture media, purification resins, and disposable bags growing significantly in China. Over the past four years, China's domestic facility and capacity expanded by almost 25%.

KEY MARKET PARTICIPANTS

Companies playing a significant role in the global bioprocess containers market profiled in this report are

• Thermo Fisher Scientific Inc.
• Lonza
• Parker Hannifin Corp
• Merck KGaA
• Sartorius AG
• Neta Scientific Incorporated
• Rim Bio Inc.
• Finesse Solutions, Inc.
• ALLpaQ Packaging Group
• Optimum Processing Inc.

GLOBAL BIOPROCESS CONTAINERS MARKET NEWS

• A leading China-based manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical manufacturing applications, RIM Bio was acquired by Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences, in 2021.
• In 2022, Thermo Fisher Scientific opened its new single-use technology manufacturing site in Ogden, Utah. It produces the high-quality technology and materials needed for developing new vaccines and advanced therapies.

MARKET SEGMENTATION

This research report on the global bioprocess containers market has been segmented and sub-segmented based on type, application, end-user, and region.

By Type

• 2D bioprocess containers
• 3D bioprocess containers

By Application

• Process Development
• Upstream
• Downstream

By End-User

• Pharma & Biopharma Companies
• CMOs & CROs
• Academic & Research Institutes

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East Africa